$9.48
6.14% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US4495851085
Symbol
IGMS
Sector
Industry

IGM Biosciences Inc Target price 2024 - Analyst rating & recommendation

IGM Biosciences Inc Classifications & Recommendation:

Buy
50%
Hold
40%
Sell
10%

IGM Biosciences Inc Price Target

Target Price $20.56
Price $9.47
Potential
Number of Estimates 9
9 Analysts have issued a price target IGM Biosciences Inc 2025 . The average IGM Biosciences Inc target price is $20.56. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 5 Analysts recommend IGM Biosciences Inc to buy, 4 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the IGM Biosciences Inc stock has an average upside potential 2025 of . Most analysts recommend the IGM Biosciences Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 2.13 2.43
99.07% 14.17%
EBITDA Margin -11,980.28% -8,743.81%
41.02% 27.01%
Net Margin -13,145.99% -8,018.59%
55.53% 39.00%

10 Analysts have issued a sales forecast IGM Biosciences Inc 2024 . The average IGM Biosciences Inc sales estimate is

$2.4m
Unlock
. This is
16.72% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.0m 2.74%
Unlock
, the lowest is
$2.0m 31.51%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $2.1m 99.07%
2024
$2.4m 14.17%
Unlock
2025
$5.9m 141.17%
Unlock
2026
$11.3m 92.54%
Unlock
2027
$26.2m 132.08%
Unlock
2028
$33.9m 29.21%
Unlock

3 Analysts have issued an IGM Biosciences Inc EBITDA forecast 2024. The average IGM Biosciences Inc EBITDA estimate is

$-213m
Unlock
. This is
0.49% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-210m 0.90%
Unlock
, the lowest is
$-215m 1.61%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-255m 17.41%
2024
$-213m 16.67%
Unlock
2025
$-168m 21.00%
Unlock
2026
$-185m 10.21%
Unlock

EBITDA Margin

2023 -11,980.28% 41.02%
2024
-8,743.81% 27.01%
Unlock
2025
-2,864.11% 67.24%
Unlock
2026
-1,639.33% 42.76%
Unlock

6 IGM Biosciences Inc Analysts have issued a net profit forecast 2024. The average IGM Biosciences Inc net profit estimate is

$-195m
Unlock
. This is
10.14% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-177m 18.36%
Unlock
, the lowest is
$-205m 5.48%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-280m 11.47%
2024
$-195m 30.36%
Unlock
2025
$-125m 35.88%
Unlock
2026
$-113m 9.95%
Unlock
2027
$-111m 1.45%
Unlock
2028
$-118m 6.25%
Unlock

Net Margin

2023 -13,145.99% 55.53%
2024
-8,018.59% 39.00%
Unlock
2025
-2,132.13% 73.41%
Unlock
2026
-997.14% 53.23%
Unlock
2027
-423.45% 57.53%
Unlock
2028
-348.21% 17.77%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -4.71 -3.28
11.47% 30.36%
P/E negative
EV/Sales 160.38

6 Analysts have issued a IGM Biosciences Inc forecast for earnings per share. The average IGM Biosciences Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-3.28
Unlock
. This is
10.14% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-2.98 18.36%
Unlock
, the lowest is
$-3.45 5.48%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-4.71 11.47%
2024
$-3.28 30.36%
Unlock
2025
$-2.10 35.98%
Unlock
2026
$-1.89 10.00%
Unlock
2027
$-1.87 1.06%
Unlock
2028
$-1.98 5.88%
Unlock

P/E ratio

Current -2.60 202.33%
2024
-2.89 11.15%
Unlock
2025
-4.50 55.71%
Unlock
2026
-5.00 11.11%
Unlock
2027
-5.07 1.40%
Unlock
2028
-4.77 5.92%
Unlock

Based on analysts' sales estimates for 2024, the IGM Biosciences Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

160.38
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
231.57
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 133.57 306.09%
2024
160.38 20.07%
Unlock
2025
66.50 58.53%
Unlock
2026
34.54 48.06%
Unlock
2027
14.88 56.91%
Unlock
2028
11.52 22.61%
Unlock

P/S ratio

Current 192.85 35.40%
2024
231.57 20.08%
Unlock
2025
96.02 58.53%
Unlock
2026
49.87 48.06%
Unlock
2027
21.49 56.91%
Unlock
2028
16.63 22.61%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today